Unknown

Dataset Information

0

Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer.


ABSTRACT: Despite the significant contribution of radiotherapy to non-small lung cancer (NSCLC), radioresistance still occurs. One of the major radioresistance mechanisms is the hyperactivation of the PI3K/Akt pathway in which Akt facilitates the repair of DNA double-strand breaks (DSBs) through the stimulation of DNA-PKcs. We investigated if targeting PI3K would be a potential approach for enhancing the radiosensitivity of K-RAS mutated (K-RASmut) NSCLC cell lines A549 and H460. Short-term (1-2 h) pre-treatment of cells with the PI3K inhibitor PI-103 (1 ?M) inhibited Akt/DNA-PKcs activity, blocked DSBs repair and induced radiosensitivity, while long-term (24 h) pre-treatment did not. Lack of an effect after 24 h of PI-103 pre-treatment was due to reactivation of K-Ras/MEK/ERK-dependent Akt. However, long-term treatment with the combination of PI-103 and MEK inhibitor PD98059 completely blocked reactivation of Akt and impaired DSBs repair through non-homologous end joining (NHEJ) leading to radiosensitization. The effect of PI3K inhibition on Akt signaling was also tested in A549 mouse xenografts. P-Akt and P-DNA-PKcs were inhibited 30 min post-irradiation in xenografts, which were pretreated by PI-103 30 min before irradiation. However, Akt was reactivated 30 min post-irradiation in tumors, which were pre-treated for 3 h with PI-103 before irradiation. After a 24 h pretreatment with PI-103, a significant reactivation of Akt was achieved 24 h after irradiation. Thus, due to MEK/ERK-dependent reactivation of Akt, targeting PI3K alone is not a suitable approach for radiosensitizing K-RASmut NSCLC cells, indicating that dual targeting of PI3K and MEK is an efficient approach to improve radiotherapy outcome.

SUBMITTER: Toulany M 

PROVIDER: S-EPMC5190057 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer.

Toulany Mahmoud M   Iida Mari M   Keinath Simone S   Iyi Firdevs F FF   Mueck Katharina K   Fehrenbacher Birgit B   Mansour Wael Y WY   Schaller Martin M   Wheeler Deric L DL   Rodemann H Peter HP  

Oncotarget 20160701 28


Despite the significant contribution of radiotherapy to non-small lung cancer (NSCLC), radioresistance still occurs. One of the major radioresistance mechanisms is the hyperactivation of the PI3K/Akt pathway in which Akt facilitates the repair of DNA double-strand breaks (DSBs) through the stimulation of DNA-PKcs. We investigated if targeting PI3K would be a potential approach for enhancing the radiosensitivity of K-RAS mutated (K-RASmut) NSCLC cell lines A549 and H460. Short-term (1-2 h) pre-tr  ...[more]

Similar Datasets

| S-EPMC3945937 | biostudies-literature
| S-EPMC4613347 | biostudies-literature
| S-EPMC5933606 | biostudies-literature
| S-EPMC5395114 | biostudies-literature
| S-EPMC4244135 | biostudies-literature
| S-EPMC3903543 | biostudies-literature
| S-EPMC6019866 | biostudies-other
| S-EPMC11228449 | biostudies-literature
2022-10-01 | GSE209767 | GEO
| S-EPMC10786723 | biostudies-literature